A pH-Sensitive Nano Drug Delivery System Derived From Pullulan/Doxorubicin Conjugate

被引:81
作者
Lu, Dianxiang [1 ]
Wen, Xiantao [1 ]
Liang, Jie [1 ]
Gu, Zhongwei [1 ]
Zhang, Xingdong [1 ]
Fan, Yujiang [1 ]
机构
[1] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China
关键词
drug delivery/release; controlled release; nanomedicine; nanoassembled devices; tumor; IN-VITRO; CONTROLLED ACTIVATION; CHOLESTERYL PULLULAN; ANTICANCER DRUGS; DOXORUBICIN; NANOPARTICLES; POLYMER; CANCER; RELEASE; CARRIER;
D O I
10.1002/jbm.b.31203
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
A novel pH-sensitive nanoparticle drug delivery system for doxorubicin (DOX) is prepared. Pullulan, a natural biocompatible polysaccharide, was partly carboxymethylized; hydrazine hydrate was condensed with the carboxyl groups forming hydrazide. The hydrazide was coupled with DOX through the formation of hydrazone bond. The chemical structure of the conjugate was determined by FTIR and H-1 NMR. The pullulan/DOX conjugate nanoparticles were formed through the aggregation of hydrophobic DOX. The size and morphology of prepared nanoparticles were characterized using dynamic light scattering and transmission electron microscope. The results showed that the nanoparticles were spherical and their size was less than 100 lint. The content of DOX in conjugate was 3.18 wt %. The investigation of the release behavior in vitro indicated that the DOX was released from nanoparticles faster at pH 5.0 (62% DOX released within 24 h) than at pH 7.4 (29% DOX released within 24 h). The in vitro cytotoxicity of pullulan/DOX conjugate nanoparticles was tested by the MTT assay. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B. Appl Biomater 89B: 177-183, 2009
引用
收藏
页码:177 / 183
页数:7
相关论文
共 43 条
[1]
Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin [J].
Akiyoshi, K ;
Kobayashi, S ;
Shichibe, S ;
Mix, D ;
Baudys, M ;
Kim, SW ;
Sunamoto, J .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :313-320
[2]
Novel drug delivery system using thermoreversible gelation polymer for malignant glioma [J].
Arai, Takao ;
Joki, Tatsuhiro ;
Akiyama, Masaharu ;
Agawa, Miyuki ;
Mori, Yuichi ;
Yoshioka, Hiroshi ;
Abe, Toshiaki .
JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (01) :9-15
[3]
Associative behaviour of hydrophobically modified carboxymethylpullulan derivatives [J].
Bataille, I ;
Huguet, J ;
Muller, G ;
Mocanu, G ;
Carpov, A .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1997, 20 (03) :179-191
[4]
Nanoparticles in cancer therapy and diagnosis [J].
Brigger, I ;
Dubernet, C ;
Couvreur, P .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (05) :631-651
[5]
Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux [J].
Chavanpatil, Mahesh D. ;
Patil, Yogesh ;
Panyam, Jayanth .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 320 (1-2) :150-156
[6]
Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation:: Effect of polymer chain modification [J].
Chytil, Petr ;
Etrych, Tomas ;
Konak, Cestmir ;
Sirova, Milada ;
Mrkvan, Tomas ;
Rihova, Blanka ;
Ulbrich, Karel .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (01) :26-36
[7]
Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration [J].
Colombo, Pierre-Emmanuel ;
Boustta, Mahfoud ;
Poujol, Sylvain ;
Pinguet, Frederic ;
Rouanet, Philippe ;
Bressolle, Francoise ;
Vend, Michel .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 31 (01) :43-52
[8]
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs [J].
Constantin, M. ;
Fundueanu, G. ;
Bortolotti, F. ;
Cortesi, R. ;
Ascenzi, P. ;
Menegatti, E. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 330 (1-2) :129-137
[10]
Etrych T, 2002, MACROMOL BIOSCI, V2, P43, DOI 10.1002/1616-5195(20020101)2:1<43::AID-MABI43>3.3.CO